{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T03:21:23Z","timestamp":1782271283477,"version":"3.54.5"},"reference-count":42,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Cardiovascular Medicine"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.tcm.2019.03.002","type":"journal-article","created":{"date-parts":[[2019,3,14]],"date-time":"2019-03-14T02:57:23Z","timestamp":1552532243000},"page":"72-77","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["New approach to blood pressure control: Triple combination pill"],"prefix":"10.1016","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9642-8380","authenticated-orcid":false,"given":"Massimo","family":"Volpe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanna","family":"Gallo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuliano","family":"Tocci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tcm.2019.03.002_bib0001","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1097\/HJH.0000000000000988","article-title":"Why in 2016 are patients with hypertension not 100% controlled? A call to action","volume":"34","author":"Redon","year":"2016","journal-title":"J Hypertens"},{"key":"10.1016\/j.tcm.2019.03.002_bib0002","article-title":"2018 ESC\/ESH Guidelines for the management of arterial hypertension","author":"Williams","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/j.tcm.2019.03.002_bib0003","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.jacc.2017.11.006","article-title":"2017 ACC\/ AHA\/ AAPA\/ ABC\/ ACPM\/ AGS\/APhA\/ASH\/ASPC\/NMA\/PCNA Guideline for the prevention, detection, evaluation, and management of high blood pressure in adults","volume":"71","author":"Whelton","year":"2018","journal-title":"JACC"},{"key":"10.1016\/j.tcm.2019.03.002_bib0004","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.ccl.2010.08.002","article-title":"Treatment and control of high blood pressure in adults","volume":"28","author":"Mensah","year":"2010","journal-title":"Cardiol Clin"},{"key":"10.1016\/j.tcm.2019.03.002_bib0005","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.amjmed.2008.09.038","article-title":"Combination therapy versus monotherapy in reducing blood pressure: meta-analysis on 11,000 participants from 42 trials","volume":"122","author":"Wald","year":"2009","journal-title":"Am J Med"},{"key":"10.1016\/j.tcm.2019.03.002_bib0006","first-page":"61","article-title":"Optimizing the management of uncontrolled hypertension: what do triple fixed-dose drug combinations add?","volume":"16","author":"Thomopoulos","year":"2018","journal-title":"Curr Vasc Pharmacol"},{"key":"10.1016\/j.tcm.2019.03.002_bib0007","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1161\/HYPERTENSIONAHA.111.177592","article-title":"Cardiovascular protection by initial and subsequent combination of antihypertensive drugs in daily life practice","volume":"58","author":"Corrao","year":"2011","journal-title":"Hypertension"},{"key":"10.1016\/j.tcm.2019.03.002_bib0008","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1016\/S0140-6736(04)16451-9","article-title":"Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomized trial","volume":"363","author":"Julius","year":"2004","journal-title":"Lancet."},{"key":"10.1016\/j.tcm.2019.03.002_bib0009","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/S0140-6736(05)67185-1","volume":"366","author":"Dahl\u00f6f","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.tcm.2019.03.002_bib0010","doi-asserted-by":"crossref","first-page":"2981","DOI":"10.1001\/jama.288.23.2981","article-title":"Major outcomes in high-risk hypertensive patients randomized to angiotensin converting enzyme inhibitor or calcium channel blocker vs diuretic: the Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)","volume":"288","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.tcm.2019.03.002_bib0011","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.ijcard.2017.12.026","article-title":"Is early and fast blood pressure control important in hypertension management?","volume":"254","author":"Volpe","year":"2018","journal-title":"Int J Cardiol"},{"issue":"Nov (11)","key":"10.1016\/j.tcm.2019.03.002_bib0012","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1097\/HJH.0b013e328333146d","article-title":"Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document","volume":"27","author":"Mancia","year":"2009","journal-title":"J Hypertens"},{"key":"10.1016\/j.tcm.2019.03.002_bib0013","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.jash.2010.03.001","article-title":"Combination therapy in hypertension","volume":"4","author":"Gradman","year":"2010","journal-title":"J Am Soc Hypertens"},{"issue":"Dec (23)","key":"10.1016\/j.tcm.2019.03.002_bib0014","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1056\/NEJMoa0806182","article-title":"Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients","volume":"359","author":"Jamerson","year":"2008","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.tcm.2019.03.002_bib0015","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1161\/HYPERTENSIONAHA.109.131300","article-title":"Triple antihypertensive therapy with amlodipine, valsartan, and hydrochlorothiazide: a randomized clinical trial","volume":"54","author":"Calhoun","year":"2009","journal-title":"Hypertension"},{"issue":"6","key":"10.1016\/j.tcm.2019.03.002_bib0016","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1111\/j.1751-7176.2011.00437.x","article-title":"A titrate-to-goal study of switching patients uncontrolled on antihypertensive monotherapy to f ixed-dose combinations of amlodipine and olmesartan medoxomil +\/- hydrochlorothiazide","volume":"13","author":"Weir","year":"2011","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"10.1016\/j.tcm.2019.03.002_bib0017","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1111\/j.1751-7176.2010.00360.x","article-title":"Rationale for triple-combination therapy for management of high blood pressure","volume":"12","author":"Gradman","year":"2010","journal-title":"J Clin Hypertens (Greenwich)"},{"issue":"Jun (2)","key":"10.1016\/j.tcm.2019.03.002_bib0018","first-page":"137","article-title":"ARB-based single-pill platform to guide a practical therapeutic approach to hypertensive patients","volume":"21","author":"Volpe","year":"2014","journal-title":"High Blood Press Cardiovasc Prev"},{"issue":"Dec (4)","key":"10.1016\/j.tcm.2019.03.002_bib0019","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/s40292-017-0239-7","article-title":"Personalised single-pill combination therapy in hypertensive patients: an update of a practical treatment platform","volume":"24","author":"Volpe","year":"2017","journal-title":"High Blood Press Cardiovasc Prev"},{"key":"10.1016\/j.tcm.2019.03.002_bib0020","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1161\/HYPERTENSIONAHA.109.131300","article-title":"Triple antihypertensive therapy with amlodipine, valsartan, and hydrochlorothiazide: a randomized clinical trial","volume":"54","author":"Chaloun","year":"2009","journal-title":"Hypertension"},{"issue":"10","key":"10.1016\/j.tcm.2019.03.002_bib0021","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1038\/jhh.2010.115","article-title":"24-Hour ambulatory blood pressure control with triple-therapy amlodipine, valsartan and hydrochlorothiazide in patients with moderate to severe hypertension","volume":"25","author":"Lacourciere","year":"2011","journal-title":"J Hum Hypertens"},{"issue":"10","key":"10.1016\/j.tcm.2019.03.002_bib0022","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1007\/BF03261919","article-title":"Efficacy and safety of triple antihypertensive therapy with the olmesartan\/amlodipine\/ hydrochlorothiazide combination","volume":"32","author":"Volpe","year":"2012","journal-title":"Clin Drug Investig"},{"issue":"4","key":"10.1016\/j.tcm.2019.03.002_bib0023","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1111\/j.1524-6175.2006.03304.x","article-title":"Use of an olmesartan medoxomil-based treatment algorithm for hypertension control","volume":"6","author":"Neutel","year":"2004","journal-title":"J Clin Hypertens"},{"issue":"Jul (7)","key":"10.1016\/j.tcm.2019.03.002_bib0024","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1016\/j.clinthera.2010.07.008","article-title":"Triple therapy with olmesartan medoxomil, amlodipine besylate, and hydrochlorothiazide in adult patients with hypertension: the TRINITY multicenter, randomized, double-blind, 12-week, parallel-group study","volume":"32","author":"Oparil","year":"2010","journal-title":"Clin Ther"},{"key":"10.1016\/j.tcm.2019.03.002_bib0025","doi-asserted-by":"crossref","first-page":"67","DOI":"10.4236\/ojim.2012.22014","article-title":"Triple drug combination of telmisartan, amlodipine and hydrochlorothiazide in the treatment of essential hypertension","volume":"2","author":"Manish Maladkar","year":"2012","journal-title":"OJIM"},{"issue":"1","key":"10.1016\/j.tcm.2019.03.002_bib0026","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.clinthera.2017.11.006","article-title":"Efficacy and tolerability of telmisartan\/amlodipine\/hydrochlorothiazide versus telmisartan\/amlodipine combination therapy for essential hypertension uncontrolled with telmisartan\/amlodipine: the phase III, multicenter, randomized, double-blind TAHYTI study","volume":"40","author":"Sung","year":"2018","journal-title":"Clin Ther"},{"key":"10.1016\/j.tcm.2019.03.002_bib0027","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1185\/03007995.2014.942415","article-title":"Real-world clinical experience of amlodipine\/valsartan and amlodipine\/valsartan\/ hydrochlorothiazide in hypertension: the EXCITE study","volume":"30","author":"Sison","year":"2014","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.tcm.2019.03.002_bib0028","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1007\/s40261-014-0223-0","article-title":"Triple combination therapy in hypertension: the antihypertensive efficacy of treatment with perindopril, amlodipine, and indapamide","volume":"34","author":"Pall","year":"2014","journal-title":"Clin Drug Investig"},{"key":"10.1016\/j.tcm.2019.03.002_bib0029","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s40256-014-0067-2","article-title":"Antihypertensive efficacy of triple combination perindopril\/indapamide plus amlodipine in high-risk hypertensives: results of the PIANIST study (Perindopril-Indapamide plus AmlodipiNe in high rISk hyperTensive patients)","volume":"14","author":"Toth","year":"2014","journal-title":"Am J Cardiovasc Drugs"},{"issue":"6","key":"10.1016\/j.tcm.2019.03.002_bib0030","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1001\/jama.2018.10359","article-title":"Fixed low-dose triple combination antihypertensive medication vs usual care for blood pressure control in patients with mild to moderate hypertension in Sri Lanka. A Randomized Clinical Trial","volume":"320","author":"Webster","year":"2018","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.tcm.2019.03.002_bib0031","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1161\/01.HYP.0000254479.66645.a3","article-title":"Low-dose quadruple antihypertensive combination: more efficacious than individual agents\u2013a preliminary report","volume":"49","author":"Mahmud","year":"2007","journal-title":"Hypertension"},{"issue":"7","key":"10.1016\/j.tcm.2019.03.002_bib0032","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0041297","article-title":"Randomized Polypill crossover trial in people aged 50 and over","volume":"7","author":"Wald","year":"2012","journal-title":"PLoS One"},{"issue":"Mar (10073)","key":"10.1016\/j.tcm.2019.03.002_bib0033","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/S0140-6736(17)30260-X","article-title":"Quarter-dose quadruple combination therapy for initial treatment of hypertension: placebo-controlled, crossover, randomised trial and systematic review","volume":"389","author":"Chow","year":"2017","journal-title":"Lancet"},{"issue":"Jul (1)","key":"10.1016\/j.tcm.2019.03.002_bib0034","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1161\/HYPERTENSIONAHA.117.09202","article-title":"Efficacy and safety of quarter-dose blood pressure-lowering agents: a systematic review and meta-analysis of randomized controlled trials","volume":"70","author":"Bennett","year":"2017","journal-title":"Hypertension"},{"key":"10.1016\/j.tcm.2019.03.002_bib0035","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/jch.12040","article-title":"The efficacy and safety of triple vs dual combination of angiotensin II receptor blocker and calcium channel blocker and diuretic: a systematic review and meta-analysis","volume":"15","author":"Kizilirmak","year":"2013","journal-title":"J Clin Hypertens"},{"key":"10.1016\/j.tcm.2019.03.002_bib0036","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1186\/1475-2840-11-134","article-title":"Olmesartan\/amlodipine\/hydrochlorothiazide in participants with hypertension and diabetes, chronic kidney disease, or chronic cardiovascular disease: a subanalysis of the multicenter, randomized, double-blind, parallel-group TRINITY study","volume":"11","author":"Kereiakes","year":"2012","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.tcm.2019.03.002_bib0037","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/s40266-013-0072-1","article-title":"Combined olmesartan, amlodipine, and hydrochlorothiazide therapy in randomized patients with hypertension: a subgroup analysis of the TRINITY study by age","volume":"30","author":"Lewin","year":"2013","journal-title":"Drugs Aging"},{"key":"10.1016\/j.tcm.2019.03.002_bib0038","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1111\/jch.12133","article-title":"Olmesartan\/ amlodipine\/hydrochlorothiazide in obese participants with hypertension: a TRINITY subanalysis","volume":"15","author":"Roth","year":"2013","journal-title":"J Clin Hypertens"},{"key":"10.1016\/j.tcm.2019.03.002_bib0039","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1161\/HYPERTENSIONAHA.113.02252","article-title":"Effects of combination of perindopril, indapamide, and calcium channel blockers in patients with type 2 diabetes mellitus: results from the Action in Diabetes and Vascular Disease: preterax and Diamicron Controlled Evaluation (ADVANCE) trial","volume":"63","author":"Chalmers","year":"2014","journal-title":"Hypertension"},{"key":"10.1016\/j.tcm.2019.03.002_bib0040","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.2146\/ajhp060434","article-title":"Adherence patterns among patients treated with fixed-dose combination versus separate antihypertensive agents","volume":"64","author":"Gerbino","year":"2007","journal-title":"Am J Health Syst Pharm"},{"key":"10.1016\/j.tcm.2019.03.002_bib0041","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1161\/HYPERTENSIONAHA.112.194167","article-title":"Initial monotherapy and combination therapy and hypertension control the first year","volume":"59","author":"Egan","year":"2012","journal-title":"Hypertension"},{"issue":"Feb (3)","key":"10.1016\/j.tcm.2019.03.002_bib0042","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1136\/heartjnl-2018-313492","article-title":"Fixed-dose combination antihypertensives and risk of medication errors","volume":"105","author":"Moriarty","year":"2019","journal-title":"Heart"}],"container-title":["Trends in Cardiovascular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1050173819300313?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1050173819300313?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T04:58:56Z","timestamp":1760936336000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1050173819300313"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":42,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["S1050173819300313"],"URL":"https:\/\/doi.org\/10.1016\/j.tcm.2019.03.002","relation":{},"ISSN":["1050-1738"],"issn-type":[{"value":"1050-1738","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"New approach to blood pressure control: Triple combination pill","name":"articletitle","label":"Article Title"},{"value":"Trends in Cardiovascular Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tcm.2019.03.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}